Works matching IS 03065251 AND DT 2011 AND VI 72 AND IP 5


Results: 19
    1
    2
    3
    4
    5

    Effect of nicotine on cytochrome P450 1A2 activity.

    Published in:
    British Journal of Clinical Pharmacology, 2011, v. 72, n. 5, p. 836, doi. 10.1111/j.1365-2125.2011.04023.x
    By:
    • Hukkanen, Janne;
    • Jacob III, Peyton;
    • Peng, Margaret;
    • Dempsey, Delia;
    • Benowitz, Neal L.
    Publication type:
    Article
    6
    7
    8
    9

    Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe.

    Published in:
    British Journal of Clinical Pharmacology, 2011, v. 72, n. 5, p. 727, doi. 10.1111/j.1365-2125.2011.03987.x
    By:
    • Johnston, Atholl;
    • Asmar, Roland;
    • Dahlöf, Björn;
    • Hill, Kate;
    • Jones, David Albert;
    • Jordan, Jens;
    • Livingston, Michael;
    • MacGregor, Graham;
    • Sobanja, Michael;
    • Stafylas, Panagiotis;
    • Rosei, Enrico Agabiti;
    • Zamorano, José
    Publication type:
    Article
    10
    11
    12
    13

    Medical management of paraquat ingestion.

    Published in:
    British Journal of Clinical Pharmacology, 2011, v. 72, n. 5, p. 745, doi. 10.1111/j.1365-2125.2011.04026.x
    By:
    • Gawarammana, Indika B.;
    • Buckley, Nicholas A.
    Publication type:
    Article
    14

    Generic substitution.

    Published in:
    British Journal of Clinical Pharmacology, 2011, v. 72, n. 5, p. 731, doi. 10.1111/j.1365-2125.2011.03920.x
    By:
    • Posner, John;
    • Griffin, John P.
    Publication type:
    Article
    15
    16
    17
    18
    19